Alnylam Pharmaceuticals ALNY Total costs & expenses
Total costs & expenses at other companies
Other financials
Where this comes from
Reported directly by Alnylam Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:CostsAndExpenses.
The official record: Alnylam Pharmaceuticals’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →
Ask your AI about Alnylam Pharmaceuticals's total costs & expenses.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Alnylam Pharmaceuticals's total costs & expenses?
- Alnylam Pharmaceuticals (ALNY) reported total costs & expenses of $898.54M in Q1 2026.
- How has Alnylam Pharmaceuticals's total costs & expenses changed year-over-year?
- Alnylam Pharmaceuticals's total costs & expenses increased by 56.0% year-over-year, from $576.11M to $898.54M.
- What is the long-term trend for Alnylam Pharmaceuticals's total costs & expenses?
- Over 4 years (2021 to 2025), Alnylam Pharmaceuticals's total costs & expenses has grown at a 19.9% compound annual growth rate (CAGR), from $1.55B to $3.21B.